Finasteride dose-dependently reduces the proliferation rate of the LnCap human prostatic cancer cell line in vitro
- 1 February 1995
- Vol. 45 (2) , 282-290
- https://doi.org/10.1016/0090-4295(95)80019-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Presence of 11 β‐hydroxysteroid dehydrogenase enzyme in the human prostate tumor cell line LNCaPThe Prostate, 1993
- The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogensThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Cancer statistics, 1991CA: A Cancer Journal for Clinicians, 1991
- Interaction between Prostatic Fibroblast and Epithelial Cells in Culture: Role of Androgen*Endocrinology, 1989
- Morphologic and regulatory aspects of prostatic functionBrain Structure and Function, 1989
- Hormonal effects of an orally active 4‐azasteroid inhibitor of 5α‐reductase in humansThe Prostate, 1989
- Early Diagnosis of Prostatic Carcinoma Based on in vitro Culture of Viable Tumor Cells Harvested by Prostatic MassageEuropean Urology, 1988
- Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaPThe Prostate, 1988